These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 18987447

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Spontaneous hemoperitoneum in recurrent jejunal gastrointestinal stromal tumor after imatinib therapy.
    Yin TC, Fan WC, Huang CJ, Hsieh JS.
    Kaohsiung J Med Sci; 2013 Jul; 29(7):402-3. PubMed ID: 23768706
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Preoperative imatinib for patients with primary unresectable or metastatic/recurrent gastrointestinal stromal tumor.
    Shen C, Chen H, Yin Y, Chen J, Zhang B, Chen Z, Chen J.
    Clinics (Sao Paulo); 2014 Nov; 69(11):758-62. PubMed ID: 25518034
    [Abstract] [Full Text] [Related]

  • 6. Is imatinib justified as an adjuvant chemotherapy for patients with recurrent gastrointestinal stromal tumors.
    Lai IR, Hu RH, Chang KJ.
    Hepatogastroenterology; 2005 Nov; 52(63):826-8. PubMed ID: 15966213
    [Abstract] [Full Text] [Related]

  • 7. [Imatinib mesylate alone for refractory advanced gastrointestinal stromal tumor].
    Shen L, Jin ML.
    Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):697-9. PubMed ID: 15777512
    [Abstract] [Full Text] [Related]

  • 8. Gastrointestinal stromal tumors: current management.
    Pisters PW, Patel SR.
    J Surg Oncol; 2010 Oct 01; 102(5):530-8. PubMed ID: 20063363
    [Abstract] [Full Text] [Related]

  • 9. [A case of gastrointestinal stromal tumor with liver and bone metastases effectively treated with radiofrequency ablation and imatinib mesylate].
    Ishikawa A, Teratani T, Ono S, Ochiai T, Kakinoki N, Kishimoto Y, Kamoshida T, Hirai S, Oka Y, Shimokama T.
    Nihon Shokakibyo Gakkai Zasshi; 2006 Nov 01; 103(11):1274-9. PubMed ID: 17085910
    [Abstract] [Full Text] [Related]

  • 10. Recurrent gastrointestinal stromal tumor (GIST) of the stomach associated with a novel c-kit mutation after imatinib treatment.
    Koyama T, Nimura H, Kobayashi K, Marushima H, Odaira H, Kashimura H, Mitsumori N, Yanaga K.
    Gastric Cancer; 2006 Nov 01; 9(3):235-9. PubMed ID: 16952044
    [Abstract] [Full Text] [Related]

  • 11. [A case of imatinib-resistant GIST treated by sunitinib].
    Sakamoto Y, Akimoto H, Kojo M, Kawano H, Chinen Y, Morita K, Sugiyama M, Saeki H, Minami K, Soejima Y, Sakaguchi Y, Toh Y, Okamura T.
    Gan To Kagaku Ryoho; 2011 May 01; 38(5):827-30. PubMed ID: 21566447
    [Abstract] [Full Text] [Related]

  • 12. Malignant gastrointestinal stromal tumor of the small intestine complicated with pulmonary tuberculosis during treatment with imatinib mesylate.
    Takashima M, Igaki N, Matsuda T, Ohyama M, Kanda S, Tamada F, Goto T.
    Intern Med; 2005 Feb 01; 44(2):114-9. PubMed ID: 15750270
    [Abstract] [Full Text] [Related]

  • 13. Imatinib mesylate induces responses in patients with liver metastases from gastrointestinal stromal tumor failing intra-arterial hepatic chemotherapy.
    Fiorentini G, Bernardeschi P, Rossi S, Dentico P, Biancalani M, Giustarini G, Turrisi G.
    J Cancer Res Ther; 2006 Feb 01; 2(2):68-71. PubMed ID: 17998678
    [Abstract] [Full Text] [Related]

  • 14. Gastrointestinal stromal tumor (GIST) -- single center experience of prolonged treatment with imatinib.
    Schindler CG, Armbrust T, Gunawan B, Langer C, Füzesi L, Ramadori G.
    Z Gastroenterol; 2005 Mar 01; 43(3):267-73. PubMed ID: 15765299
    [Abstract] [Full Text] [Related]

  • 15. Malignant stromal tumor of the stomach with giant cystic liver metastases prior to treatment with imatinib mesylate.
    Colović R, Micev M, Matić S, Colović N, Grubor N, Atkinson HD.
    Vojnosanit Pregl; 2013 Feb 01; 70(2):225-8. PubMed ID: 23607193
    [Abstract] [Full Text] [Related]

  • 16. Soft tissue calcification secondary to imatinib mesylate in a patient with gastrointestinal stromal tumor.
    Enck RE, Abushahin F, Bossaer JB.
    J Oncol Pharm Pract; 2014 Apr 01; 20(2):137-40. PubMed ID: 23676509
    [Abstract] [Full Text] [Related]

  • 17. Imaging characteristics of liver metastasis from gastrointestinal stromal tumor before and after imatinib mesylate treatment.
    Ulusan S, Koç Z, Kayaselçuk F.
    Turk J Gastroenterol; 2008 Jun 01; 19(2):129-32. PubMed ID: 19110671
    [Abstract] [Full Text] [Related]

  • 18. Duodenal perforation caused by imatinib mesylate during adjuvant treatment of gastric stromal tumor: Case report.
    Liao MJ, Wu YQ, Lu T, Yang QB.
    Int J Clin Pharmacol Ther; 2021 Jun 01; 59(6):467-470. PubMed ID: 33605877
    [Abstract] [Full Text] [Related]

  • 19. Approval summary: imatinib mesylate in the adjuvant treatment of malignant gastrointestinal stromal tumors.
    Cohen MH, Cortazar P, Justice R, Pazdur R.
    Oncologist; 2010 Jun 01; 15(3):300-7. PubMed ID: 20200041
    [Abstract] [Full Text] [Related]

  • 20. A multicenter long-term study of imatinib treatment for Japanese patients with unresectable or recurrent gastrointestinal stromal tumors.
    Ogata K, Mochiki E, Ojima H, Haga N, Fukuchi M, Aihara R, Ando H, Uchida N, Toyomasu Y, Suzuki M, Kimura A, Kogure N, Yokobori T, Ohno T, Kuwano H.
    J Surg Oncol; 2014 Dec 01; 110(8):942-6. PubMed ID: 25164620
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.